Радикальное хирургическое лечение инвазивного рака мочевого пузыря

1. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer. Ann Oncol 2003;14:1008—9.

2. Catto J.W.F., Rosario D.J. The road to cystectomy: who,when and why? EAU Update Series 2005;3:118—28.

3. Jemal A., Tiwari R.C., Murray T. et al. Cancer Statistics, 2004. CA Cancer J Clin 2004;54:8—29.

4. Злокачественные новообразования в Беларуси 1995—2004. Под редакцией А.А.Граковича и И.В.Залуцкого. Минск, БелЦМТ; 2005.

5. Tsukamoto T., Kitamura H., Takahashi A., Masumori N. Treatment of invasive bladder cancer: lessons from the past and perspective for the future. Jpn J Clin Oncol 2004;34(6):295—306.

6. Матвеев Б.П., Фигурин К.М., Карякин О.Б. Рак мочевого пузыря. Москва, Вердана; 2001.

7. Vaidya A., Soloway M.S., Hawke C. et al. De novo muscle invasive bladder cancer: is there a change in trend? J Urol 2001;165:47—50.

8. Herr H.W., Faulkner J.R., Grossman H.B. et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004;22:2781—5.

9. Campbell’s Urology, 8th ed. Eds. P.C. Walsh et al. Vol/ 3 Philadelphia, W.B. Saunders Co.; 2002.

10. Solsona E., Iborra I., Dumont R. et al. Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity. J Urol 2005;174:1226—30.

11. Stein J.P., Lieskovsky G., Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001;19:666—75.

12. Stein J.P., Skinner D.G. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am 2005;32:187—97.

13. Hautmann R.E., Stein J.P. Neobladder with Prostatic Capsule and Seminal-sparing Cystectomy for Bladder Cancer: A Step in the Wrong Direction. Urol Clin North Am 2005;32(2):177—85.

14. Stenzl A., Nagele U., Kuczyk M. et al. Cystectomy — technical considerations in male and female patients. EAU Update Series 2005;3:138—46.

15. Gaston R., Heidenreich A. Open versus laparoscopic radical cystectomy. Eur Urol Suppl 2006;5:385—94.

16. Gill I.S., Fergany A., Klein E.A. et al. Laparoscopic radical cystoprostatectomy with ileal conduit performed completely intracorporeally: the initial 2 cases. Urology 2000;56:26—30.

17. Hrouda D., Adeyeoju A.A.B., Gill I.S. Laparoscopic radical cystectomy and urinary diversion: fad or future? BJU Int 2004;94:501—5.

18. Sorcini A., Tuerk I. Laparoscopic radical cystectomy with ileal conduit urinary diversion. Urol Oncol Semin Orig Investig 2004;22:149—52.

19. Parra R.O., Andrus C.H., Jones J.P., Boullier J.A. Laparoscopic cystectomy. Initial report on a new treatment for the retained bladder. J Urol 1992;148:1140—4.

20. De Badajoz S.E., Peralles G.J.L., Rosado A.R. et al. Laparoscopic cystectomy and ileal conduit: case report. J Endourol 1995;9:59—62.

21. Denewer A., Kotb S., Hussein O., ElMaadawy M. Laparoscopic assisted cystectomy and lymphadenectomy for bladder cancer: initial experience. World J Surg 1999;23:608—11.

22. Finelli A., Gill I.S., Desai M.M. et al. Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. J Urol 2004;172:1809—12.

23. Ghoneim M.A., Abol-Enein H. Lymphadenectomy with cystectomy: is it necessary and what is its extent? Eur Urol 2004;46(4):457—61.

24. Bochner B.H., Herr H.W., Reuter V.E. Impact of separate versus en block pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001;169:2295—6.

25. Bochner B.H., Cho D., Herr H.W. et al. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004;172:1286—90.

26. Ather M.H., Fatima S., Sinanoglu O. Extent of lymphadenectomy in radical cystectomy for bladder cancer. World J Surg Oncol 2005;43(3):1—5.

27. Stein J.P., Quek M.L., Skinner D.G. Lymphadenectomy for invasive bladder cancer: II. technical aspects and prognostic factors. BJU Int 2006;97:227—31.

28. Brössner C., Pycha A., Toth A. et al. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 2004;93:64—6.

29. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169:943—5.

30. Konety B.R., Joslyn S.A. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 2003;170:1765—71.

31. Liedberg F., Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 2006;49:13—21.

32. Sanderson K.M., Stein J.P., Skinner D.G. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer. Urol Oncol 2004;22(13):205—13.

33. Leissner J., Hohenfellner R., Thuroff J.W., Wolf H.K. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000;85:817—23.

34. Herr H.W. Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality). BJU Int 2003;92:187—8.

35. Madersbacher S., Hochreiter W., Burkhard F. et al. Radical cystectomy for bladder cancer today — a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690—6.

36. Gschwend J.E., Fair W.R., Vieweg J. Radical cystectomy for invasive bladder cancer: Contemporary results and remaining controversies. Eur Urol 2000;38(2):121—30.

37. Gschwend J.E. Bladder substitution. Curr Opin Urol 2003;13:477—82.

38. Мавричев А.С., Красный С.А., Поляков С.Л. и др. Онкоурология. Минск, БелЦНМИ, 2001.

39. Yossepowitch O., Baniel J. Ureterosigmoidostomy and obstructive uropathy. Nature Clin Pract Urol 2005;2(10):511—5.

40. Nitkunan T., Leaver R., Patel H.R.H., Woodhouse C.R.J. Modified ureterosigmoidostomy (Mainz II): a long-term follow-up. BJU Int 2004;93:1043—7.

41. Hautmann R.E. Urinary diversion: ileal conduit to neobladder. J Urol 2003;169:834—8.

42. Lusuardi L., Lodde M., Pycha A. Surgical Atlas: Cutaneous ureterostomy. BJU Int 2005;96:1149—59.

43. Meyer J.-P., Fawcett D., Gillatt D., Persad R. Orthotopic neobladder reconstruction — what are the options? BJU Int 2005;96:493—7.

44. Hautmann R.E., De Petriconi Ft., Gottfried H.W. et al. The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol 1999;161(2):422—8.

45. Konety B.R., Dhawan V., Allareddy V., Joslyn S.A. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 2005;173:1695—700.

46. Hollenbeck B.K., Miller D.C., Taub D. et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174:1231—7.

47. McCabe J.E., Jibawi A., Javle P. Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy. BJU Int 2005;96:806—10.

48. Gerharz E.W., Roosen A., Mansson W. Complications and Quality of Life Following Urinary Diversion After Cystectomy. EAU Update Series 2005;3:156—68.

49. Inman B.A., Harel F., Tiguert R. et al. Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients. J Urol 2003;170:1888—91.

50. Park H.K., Kwak C., Byun S. et al. Early removal of nasogastric tube after cystectomy with urinary diversion: does postoperative ileus risk increase? Urology 2005;65:905—8.

51. Carrion R., Arap S., Corcione G. et al. A multiinstitutional study of orthotopic neobladders: functional results in men and women. BJU Int 2004;93:803—6.

52. Woodhouse C.R.J., Robertson W.G. Urolithiasis in enterocystoplasties. World J Urol 2004;22:215—21.

53. Gerharz E.W., McDougal W.S. Metabolic and functional consequences of urinary diversion through intestinal segments. World J Urol 2004;22:155—6.

54. Roosen A., Gerharz E.W., Roth St., Woodhouse C.R.J. Bladder, bowel and bones — skeletal changes after intestinal urinary diversion. World J Urol 2004;22:200—9.

55. Riddick A.C., Turner W.H., Mills R.D. Bowel function in urinary diversion. World J Urol 2004;22:210—4.

56. Meyer J.-P., Drake B., Boorer J. et al. A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results. BJU Int 2004;94:1317—21.

57. Pickard R. Tumour formation within intestinal segments transposed to the urinary tract. World J Urol 2004;22:227—34.

58. Zebic N., Weinknecht S., Kroepfl D. Radical cystectomy in patients aged ≥75 years: an updated review of patients treated with curative and palliative intent. BJU Int 2005;95:1211—4.

59. Deliveliotis C., Papatsoris A., Chrisofos M. et al. Urinary diversion in hidh-risk elderly patients: Modified cutaneous ureterostomy or ileal conduit? Urology 2005;66:299—304.

60. Lodde M., Pycha A., Palermo S. et al. Uretero-ureterocutaneostomy (wrapped by omentum). BJU Int 2005;95:371—3.

61. Clark P.E., Stein J.P., Groshen S.G. et al. Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer 2005;103:546—52.

62. Hollenbeck B.K., Miller D.C., Taub D. et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004;64:292—7.

63. Mansson A., Henningsohn L., Steineck G., Mansson W. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eur Urol 2004;46:195—9.

64. öhrström M., Davidsson Th., Mаnsson W. et al. Working сapacity and well-being after radical cystectomy with continent cutaneous diversion. Eur Urol 2006;49:691—7.

65. Lee K.S., Montie J.E., Dunn R.L., Lee C.T. Hautmann and Studer orthotopic neobladders: a contemporary experience. J Urol 2003;169:2188—91.

66. Colombo R., Bertini R., Salonia A. et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 2004;171:1819—22.

67. Martis G., D'Elia G., Diana M. et al. Prostatic capsuleand nerve-sparing cystectomy in organ-confined bladder cancer: preliminary results. World J Surg 2005;29:1277—81.

68. Nandipati K.C., Bhat A., Zippe C.D. Neurovascular preservation in female orhtotopic radical cystectomy significantly improves sexual function. Urology 2006;67:185—6.

69. Zippe C.D., Nandipati K.C., Agarwal A. et al. Female sexual dysfunction after pelvic surgery: impact of surgical modifications. BJU Int 2005;96:959—63.

70. Kent E., Sandler H., Montie J. et al. Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol 2004;22:2540—5.

71. Shipley W.U., Kaufman D.S., Zehr E. et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002;60:62—8.

72. Sternberg C.N., Parmar M.K. Neo-adjuvant chemotherapy is not (yet) standard treatment for muscle invasive bladder cancer. J Clin Oncol 2001;19(Suppl 1):21S—26S.

73. Montie J.E. Against bladder sparing surgery. J Urol 1999;162:452—7.

74. Natale R.B., Grossman H.B., Blumenstein B. et al. SWOG 8710 (INT-0800). Randomized phase III trial of neoadjuvant MVAC+cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. Proc Am Soc Clin Oncol 2001;20:3—7.

75. Sternberg C.N., Pansadoro V. Muscleinvasive transitional cell carcinoma of the bladder: Strategies for bladder preservation. Curr Opin Urol 1998;(8):431—5.

76. Bianco Jr.F.J., Justa D., Grignon D.J. et al. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004;22:290—4.

77. Hassan J.M., Cookson M.S., Smith Jr.J.A. et al. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol 2004;172:882—4.

78. Freeman J.A., Esrig D., Stein J.P. et al. Radical cystectomy for high-risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995;76:833—9.

79. Pagano F., Bassi P., Galetti T.P. et al. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45—50.

80. Jichlinski P. New diagnostic strategies in the detection and staging of bladder cancer. Curr Opin Urol 2003;13:351—5.

81. Tekes A., Kamel I., Imam K. et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005;184:121—7.

82. Hoshi S., Orikasa S., Suzuki K. et al. Diagnosis and treatment of pelvic lymph node metastasis in bladder cancer. Int J Urol 1999;6:400—7.

83. Frank I., Cheville J.C., Blute M.L. et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer 2003;97:2425—30.

84. El-Tabey N.A., Osman Y., Mosbah A. et al. Bladder cancer with obstructive uremia: oncologic outcome after definitive surgical management. Urology 2005;66:531—5.

85. Bochner B.H., Montie J.E., Lee C.T. Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am 2003;30(4):777—89.

86. Kuczyk M., Turkeri L., Hammerer P., Ravery V. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer? Eur Urol 2003;44:57—64.

87. Solsona E., Iborra I., Rubio J. et al. Late oncological occurrences following radical cystectomy in patients with bladder cancer. Eur Urol 2003;43:489—94.

88. Herr H.W., Bochner B.H., Dalbagni G. et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002;167:1295—8.

89. Thalmann G.N., Fleishman A., Mills R.D. et al. Lymphadenectomy in bladder cancer. EAU Update Series 2003;(1):100—7.

90. Westney O.L., Pister L.L., Pettaway C.A. et al. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1998;159:792—5.

91. Kakizoe T., Tobisu K. Transitional cell carcinoma of the urethra in men and women associated with bladder cancer. Jpn J Clin Oncol 1998;28:357—9.

92. Freeman J.A., Esrig D., Stein J.P., Skinner D.G. Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am 1994;21(4):645—51.

93. Hickey D.P., Soloway M.S., Murphy W.M. Selective urethrectomy following cystoprostatectomy for bladder cancer. J Urol 1986;136:828—30.

94. Lin D.W., Herr H.W., Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol 2003;169:961—3.

95. Yamashita S., Hoshi S., Ohyama C. et al. Urethral recurrence following neobladder in bladder cancer patients. Tohoku J Exp Med 2003;199:197—203.

96. Freeman J., Tarter T.A., Esrig D. et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 1996;156:1615—9.

97. Tobisu K., Kanai Y., Sakamoto M. et al. Involvement of the anterior urethra in male patients with transitional cell carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy. Jpn J Clin Oncol 1997;27:406—9.

98. Elmajian D.A. Indications for urethrectomy. Semin Urol Oncol 2001;19:37—44.

99. Stenzl A., Draxl H., Posch B. et al. The risk of urethral tumors in female bladder cancer: Can the urethra be used for orthotopic reconstruction of the lower urinary tract? J Urol 1995;153:950—5.

100. Stein J.P., Ginsberg D.A., Skinner D.G. Indications and technique of the orthotopic neobladder in women. Urol Clin North Am 2002;29:725—34.

101. Van Poppel H., Sorgeloose T. Radical cystectomy with or without urethrectomy? Crit Rev Oncol Hematol 2003;47(2):141—5.

102. Fleischmann A., Thalmann G.N., Markwalder R., Studer U.E. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol 2005;29:89—95.

103. Nishiyama N., Masumori N., Satoh E. et al. Role of cystectomy for patients with invasive bladder cancer having metastasis. Hinyoki Geka 2003;16:1195—9.